Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Vipul Jairath"'
Autor:
Christopher Ma, Alain M. Schoepfer, Ekaterina Safroneeva, Evan S. Dellon, Albert J. Bredenoord, Mirna Chehade, Margaret H. Collins, Brian G. Feagan, Glenn T. Furuta, Sandeep K. Gupta, Ikuo Hirano, Vipul Jairath, David A. Katzka, Rish K. Pai, Marc E. Rothenberg, Alex Straumann, Seema S. Aceves, Jeffrey A. Alexander, Nicoleta C. Arva, Dan Atkins, Luc Biedermann, Carine Blanchard, Antonella Cianferoni, Constanza Ciriza de los Rios, Frederic Clayton, Carla M. Davis, Nicola de Bortoli, Jorge A. Dias, Gary W. Falk, Robert M. Genta, Gisoo Ghaffari, Nirmala Gonsalves, Thomas Greuter, Russell Hopp, Karen S. Hsu Blatman, Elizabeth T. Jensen, Doug Johnston, Amir F. Kagalwalla, Helen M. Larsson, John Leung, Hubert Louis, Joanne C. Masterson, Calies Menard-Katcher, Paul A. Menard-Katcher, Fouad J. Moawad, Amanda B. Muir, Vincent A. Mukkada, Roberto Penagini, Robert D. Pesek, Kathryn Peterson, Philip E. Putnam, Alberto Ravelli, Edoardo V. Savarino, Christoph Schlag, Philipp Schreiner, Dagmar Simon, Thomas C. Smyrk, Jonathan M. Spergel, Tiffany H. Taft, Ingrid Terreehorst, Tim Vanuytsel, Carina Venter, Mario C. Vieira, Michael Vieth, Berber Vlieg-Boerstra, Ulrike von Arnim, Marjorie M. Walker, Joshua B. Wechsler, Philip Woodland, John T. Woosley, Guang-Yu Yang, Noam Zevit
Publikováno v:
Gastroenterology, 161(3), 778-784. W.B. Saunders Ltd
The Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS) collaborators are a group of more than 70 gastroenterologists, pathologists, allergists, researchers, dietitians, psychologists, and methodologists who convened in a se
Publikováno v:
Journal of the Canadian Association of Gastroenterology
Background Multidisciplinary conference presentation may provide recommendations for diagnosis, monitoring and treatment for patients with inflammatory bowel disease. Methods A prospective observational study was completed evaluating if case presenta
Autor:
Neeraj Narula, Emily C L Wong, Vipul Jairath, Gursimran Kochhar, Parambir S. Dulai, Jean-Frederic Colombel, William J. Sandborn
Publikováno v:
Am J Gastroenterol
BACKGROUND: Cost-effectiveness of biomarker- versus endoscopy-based treat-to-target monitoring in Crohn’s disease (CD) is unknown. METHODS: A microsimulation model for CD was built to simulate biomarker (fecal calprotectin) versus endoscopy-based m
Autor:
Thomas M Goodsall, Tran M Nguyen, Robert V Bryant, Samuel P Costello, Richard Noy, Vipul Jairath
Publikováno v:
Journal of the Canadian Association of Gastroenterology
Background and Aims Inflammatory bowel disease (IBD) is a lifelong disease requiring frequent assessment to guide treatment and prevent flares or progression. Multiple tools are available for clinicians to monitor disease activity; however, there are
Autor:
Brian G. Feagan, Christopher Ma, Marija Andic, Eileen Crowley, Anne M. Griffiths, Vipul Jairath
Publikováno v:
Journal of Crohn'scolitis. 16(2)
Background and Aims Timely access to approved medications is a priority in paediatric inflammatory bowel disease [IBD]. To date, the timing of drug studies in paediatric IBD has been suboptimal, with most studies conducted long after approval has bee
Publikováno v:
Clinical Gastroenterology and Hepatology. 17:1904-1908
Fistulizing complications develop in approximately one third of patients with Crohn's disease (CD), resulting in morbidity and impaired quality of life.1 Sites of fistulae most commonly include perianal fistulae, but also enterocutaneous, enteroenter
Autor:
Ioannis E. Koutroubakis, Simon Travis, Edward V. Loftus, Bruce E. Sands, Yehuda Chowers, Arthur Kaser, Antonino Spinelli, Maria T. Abreu, Gerassimos J. Mantzaris, Gerhard Rogler, Parambir S. Dulai, Milan Lukas, Dan Turner, Ailsa Hart, Colm O'Morain, Jonas Halfvarson, Matthieu Allez, Severine Vermeire, Silvio Danese, Geert R. D'Haens, William J. Sandborn, Walter Reinisch, Siew C. Ng, Subrata Ghosh, Flavio Steinwurz, Pia Munkholm, Jean-Frederic Colombel, Remo Panaccione, Stefan Schreiber, David B. Sachar, Laurent Peyrin-Biroulet, Julián Panés, Vipul Jairath, Aswhin N. Ananthakrishnan, Peter R. Gibson, Wolfgang Kruis, Catherine Le Berre, Iris Dotan, David T. Rubin
Publikováno v:
Gastroenterology
Gastroenterology, WB Saunders, 2021, 160 (5), pp.1452-1460.e21. ⟨10.1053/j.gastro.2020.10.065⟩
Gastroenterology, 160(5), 1452-1460.e21. W.B. Saunders Ltd
Gastroenterology, Elsevier, 2021, 160 (5), pp.1452-1460.e21. ⟨10.1053/j.gastro.2020.10.065⟩
Gastroenterology, WB Saunders, 2021, 160 (5), pp.1452-1460.e21. ⟨10.1053/j.gastro.2020.10.065⟩
Gastroenterology, 160(5), 1452-1460.e21. W.B. Saunders Ltd
Gastroenterology, Elsevier, 2021, 160 (5), pp.1452-1460.e21. ⟨10.1053/j.gastro.2020.10.065⟩
International audience; Background and aims: Inflammatory bowel diseases (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), are chronic and disabling disorders. Prospective disease-modification trials to prevent disease progression
Publikováno v:
Rheumatology and Therapy
Rheumatology and Therapy, Vol 7, Iss 1, Pp 35-64 (2020)
Rheumatology and Therapy, Vol 7, Iss 1, Pp 35-64 (2020)
The act of nonmedical switching, defined as switching stable patients who are generally doing well with their current therapy from an originator biologic to its biosimilar, has been endorsed as a reasonable treatment strategy. The safety and efficacy
Autor:
Gary S. Collins, Vipul Jairath, Michael F. Murphy, Neil Mortensen, Kathryn Oakland, Raman Uberoi, Richard H. Guy, Lakshmana Ayaru
Publikováno v:
The Lancet Gastroenterology & Hepatology. 2:635-643
Summary Background Acute lower gastrointestinal bleeding is a common reason for emergency hospital admission, and identification of patients at low risk of harm, who are therefore suitable for outpatient investigation, is a clinical and research prio
Publikováno v:
Gastroenterology Clinics of North America. 46:661-677
Despite advances in care, most patients with Crohn's disease (CD) develop complications, such as fistulas, or require surgery. Given the recent advances in drug therapy, an opportunity exists to optimize the management of this chronic disease through